Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factor receptor-bound protein 7 (GRB7) is an adaptor protein that contains Src homology 2 (SH2) and pleckstrin homology (PH) domains, enabling it to interact with receptor tyrosine kinases such as EGFR and ERBB2 (HER2), as well as focal adhesion kinase (FAK). GRB7 modulates key intracellular signaling pathways linked to cell migration, proliferation, and integrin signaling, with prominent roles in cancer cell invasion and metastasis. The GRB7 gene is frequently co-amplified with ERBB2 in multiple cancers and its overexpression is associated with poor patient prognosis, making it both a candidate prognostic biomarker and a potential therapeutic target, particularly in HER2-positive tumors. Experimental peptide inhibitors targeting the SH2 domain have shown preclinical anti-cancer activity by disrupting its protein-protein interactions, although no approved GRB7-specific drugs are available.
Inhibition of GRB7 SH2 domain interaction with phosphorylated receptor tyrosine kinases (e.g., EGFR, ERBB2) to block downstream signaling and migration; suppression of integrin or focal adhesion signaling to reduce tumor cell invasiveness
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth factor receptor-bound protein 7 (GRB7).